Pfizer Positions on U.S. Legislation - MapLight

Pfizer Positions on U.S. Legislation

Pfizer Positions on U.S. Legislation - MapLight
Pfizer Positions on U.S. Legislation
Published Oct 23, 2020
426 pages — Published Oct 23, 2020
Price US$ 125.00  |  Buy this Report Now

About This Report

  
Abstract:

Pfizer Bill Positions
MapLight's report on Pfizer details Pfizer's support for or opposition to bills in Congress. MapLight has recorded 80 bill positions taken by Pfizer since January 1, 2007. These bills relate to topics including Government Operations and Politics, Health, Budget, Spending, and Taxes, Business and Commerce, Congress, and 52 other topics.
Support and opposition information is based on public documents found by MapLight, including congressional testimony, news reports, and company statements. These documents are included with the report.

Scope:
This report provides, for each of the 80 bills Pfizer has taken a position on, the following information:
* Bill name, number, and sponsor.
* Bill summary and status (i.e. whether the bill is in committee, has become law, etc.).
* Pfizer's position (support or opposition).
* Date Pfizer's position was taken and date it was recorded by MapLight.
* Source document for the support or opposition stance.

Source documents:
Source documents for Pfizer's support or opposition stance are authored by:
* Coalition for 21st Century Patent Reform; Letter to Chairman Leahy, Ranking Member Specter, Chairman Conyers and Ranking Member Smith; 6-14-07 (2 pages)
* United States Senate Committee on Finance; 2nd Company letter to Senate on Tax Extenders (6 pages)
* United States Senate Committee on Finance; Business Leaders Back Baucus Effort on Extenders (10 pages)
* Invest in America's Future; Company, Organization Letter to Congress on the R&D Tax Credit (7 pages)
* Pfizer; Dear Senator Feinstein (6 pages)
* dreamactivist.org; Endorsements from NYC and Major CEOs Flow in for the DREAM Act (10 pages)
* Invest in America's Future; Company, Organization Letter to Congress on the R&D Tax Credit (7 pages)
* U.S. Chamber of Commerce; Multi-industry letter opposing S. 1504, the 'Notice Pleading Restoration Act of 2009' (4 pages)
* Pfizer; Pfizer Public Policy: Importation (5 pages)
* And others.

Reasons to buy:
* Gauge future potential of Pfizer based on whether a bill they support or oppose advances or is defeated in Congress.
* Evaluate the political activity of Pfizer, including legislation of interest.
* Understand the reasoning behind Pfizer's positions on legislation through content of source documents.
* Learn of other organizations that have taken the same position as Pfizer on a bill (other signers).
* Learn of legislation which affects the financial prospects of Pfizer.
* Learn whether bills Pfizer has supported or opposed have been enacted, defeated, or are still pending.

Topics of legislation:
The bills Pfizer has taken a position on cover the following topics: Business & Labor (51), Government Affairs (47), Budget & Economy (46), Health & Welfare (41), Legal Affairs (32), Culture and Social Issues (25), Science, Technology, Communications, and Infrastructure (25), Defense, National Security and Foreign Policy (19), Natural Resources (14), Education (6). The report is 426 pages long, including 79 source documents.

  
Source:
Document ID
23373000
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MapLight—Company positions on U.S. legislation reports detail support for and opposition to bills in the U.S. Congress, for the most politically active companies, unions, associations, and interest groups. The reports are based on public documents, including company statements, news reports, and congressional testimony. These documents are included with the reports.

About the Author


Cite this Report

  
MLA:
MapLight. "Pfizer Positions on U.S. Legislation" Oct 23, 2020. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/MapLight/Pfizer-Positions-on-U-S-Legislation-2154-162>
  
APA:
MapLight. (2020). Pfizer Positions on U.S. Legislation Oct 23, 2020. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/MapLight/Pfizer-Positions-on-U-S-Legislation-2154-162>
  
US$ 125.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Company Profiles from one place.